193 related articles for article (PubMed ID: 14615149)
1. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
[TBL] [Abstract][Full Text] [Related]
3. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
Wittermann C; Schöndorf I; Gniel D
Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
[TBL] [Abstract][Full Text] [Related]
4. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
[TBL] [Abstract][Full Text] [Related]
5. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
[TBL] [Abstract][Full Text] [Related]
6. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
Harabacz I; Bock H; Jüngst C; Klockmann U; Praus M; Weber R
Vaccine; 1992; 10(3):145-50. PubMed ID: 1557929
[TBL] [Abstract][Full Text] [Related]
8. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
[TBL] [Abstract][Full Text] [Related]
9. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
[TBL] [Abstract][Full Text] [Related]
10. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunogenicity and safety between two paediatric TBE vaccines.
Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Prymula R; Angermayr R; Draxler W; Firth C; Bosman J; Valenta B; Harmacek P; Maritsch F; Barrett PN; Ehrlich HJ
Vaccine; 2010 Jun; 28(29):4680-5. PubMed ID: 20433803
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.
Pöllabauer EM; Fritsch S; Pavlova BG; Löw-Baselli A; Firth C; Koska M; Maritsch F; Barrett PN; Ehrlich HJ
Vaccine; 2010 Jun; 28(29):4558-65. PubMed ID: 20452432
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against tick-borne encephalitis--distant evaluation.
Bobrowska E; Grzeszczuk A; Prokopowicz D
Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
Beran J; Douda P; Gniel D; Zent O
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
[TBL] [Abstract][Full Text] [Related]
16. Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children.
Eder G; Kollaritsch H
Vaccine; 2003 Sep; 21(25-26):3575-83. PubMed ID: 12922085
[TBL] [Abstract][Full Text] [Related]
17. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Steffen R; Erber W; Schmitt HJ
Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
[TBL] [Abstract][Full Text] [Related]
18. Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
Yonekawa M; Watanabe T; Kogawara O; Yoshii C; Yamaji M; Aizawa M; Erber W; Ito S; Jug B; Koelch D; de Solom R; Lockhart SP
Vaccine; 2024 May; 42(13):3180-3189. PubMed ID: 38614954
[TBL] [Abstract][Full Text] [Related]
19. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
Pazdiora P; Januska J
Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance.
Pavlova BG; Loew-Baselli A; Fritsch S; Poellabauer EM; Vartian N; Rinke I; Ehrlich HJ
Vaccine; 2003 Jan; 21(7-8):742-5. PubMed ID: 12531353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
